Buscar
01/03/2026
GRADE Guidance: Update on Developing Good Practice Statements in Guidelines
Dewidar, O, Akl, EA, Morgano, GP, Parmelli, E, Saz-Parkinson, Z, Langendam, MW, Meerpohl, JJ, Marti, M, Mayer, M, Djulbegovic, B, Brignardello-Petersen, R, Chu, DK, Murad, MH, Canelo-Aybar, C, Mathew, JL, Alonso-Coello, P, Qaseem, A, Schwingshackl, L, Bognanni, A, Rojas-Reyes, MX, Morgan, RL, Klugar, M, Comas, DR, Stallings, E, Iorio, A, Tugwell, P, Darzi, A, Turgeon, AF, Shamliyan, TA, Munn, Z, Mathioudakis, AG, Piggott, T, Lotfi, T, Pottie, K, Guyatt, G, Schünemann, HJ. GRADE Guidance: Update on Developing Good Practice Statements in Guidelines. ANNALS OF INTERNAL MEDICINE. 2026; 179(3)DOI:10.7326/ANNALS-25-00431. PMID:41554128. IF:15.200(Q1/1D).
01/03/2026
Impact of matrix-construction assumptions on quantitative overlap assessment in overviews: A meta-research study
Bracchiglione, J, Meza, N, Pieper, D, Lunny, C, Vargas-Peirano, M, Vicuña, J, Briceño, F, Parra, RG, Carrasco, IP, Urrútia, G, Bonfill, X, Madrid, E. Impact of matrix-construction assumptions on quantitative overlap assessment in overviews: A meta-research study. Research Synthesis Methods. 2026; 17(2)DOI:10.1017/rsm.2025.10056. PMID:41635949. IF:6.100(Q1/1D).
01/03/2026
Integrating planetary health considerations into health guidelines: decision-making bodies must show leadership
Metzendorf, MI, Aloosh, M, Benton, L, Perez, JB, Cumpston, M, de'Donato, FK, Laot, S, Piggott, T, Rahman, KMSU, Stein, AT. Integrating planetary health considerations into health guidelines: decision-making bodies must show leadership. Bmj Leader. 2026; 10(1)DOI:10.1136/leader-2025-001277. PMID:40730455. IF:(Q/D).
01/03/2026
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Fernández-Sáenz, FK, de la Torre-Perez, L, Baldwin, DR, van der Aalst, C, Thorat, M, Ritchie, D, Carvalho, AL, Espina, C, Solà, I, Canelo-Aybar, C, Pissinis, MM, Alonso-Coello, P, Pinto, ACPN. Screening for lung cancer: A systematic review of overdiagnosis and its implications. Molecular Oncology. 2026; 20(3)DOI:10.1002/1878-0261.70139. PMID:41220098. IF:4.500(Q2/3D).